论文部分内容阅读
目的:观察补肺活血化痰法治疗慢性阻塞性肺疾病并发肺动脉高压疗效.方法:选取2014年2月～ 2016年3月于我院接受治疗的慢性阻塞性肺疾病并发肺动脉高压患者127例.按照随机数表法分为治疗组和对照组,分别为64例、63例.对照组接受常规西药治疗,观察组在其基础上进行补肺活血化痰法治疗.观察两组患者的治疗效果、肺动脉收缩压数值变化及不良事件发生情况.结果:治疗组的总有效率为95.31％,明显高于对照组的58.73％ (P＜0.05).治疗后,治疗组的肺动脉收缩压为(37.42±5.66) mmHg,明显低于对照组的(41.48±5.22) mmHg,同时也低于其治疗前的肺动脉收缩压(40.75±4.56) mmHg (P＜0.05).治疗前,两组患者肺动脉收缩压比较,差异无统计学意义(P＞0.05).两组患者不良事件发生例数均为0.结论:补肺活血化痰法治疗慢性阻塞性肺疾病并发肺动脉高压具有较好的治疗效果,能够明显降低肺动脉收缩压.“,”Objective:To explore the effect of Bufei Huoxue Huatan method in the treatment of chronic obstructive pulmonary disease complicated with pulmonary hypertension.Methods:127patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension were enrolled in our hospital from February 2014to March 2016.Randomly divided into treatment group and controlled group,64cases and 63cases respectively.The controlled group was treated with routine western medicine,and the observation group was treated with the method of treating lung and activating blood and sputum.The therapeutic effect of the two groups,pulmonary artery systolic pressure values change,adverse events were observed.Results:The total effective rate was 95.31％ in the treatment group,which was obviously higher than that in the controlledgroup (58.73％,P＜0.05).After treatment,the systolic blood pressure of the treatment group was (37.42±5.66) mmHg,which was obviously lower than that of the controlled group (41.4±5.22) mmHg,and lower than that of the controlled group (40.75±4.56) mmHg (P＜0.05).Before treatment,the two groups of patients with pulmonary artery systolic blood pressure,there was no significant difference (P＞0.05).The incidence of adverse events in both groups were zero.Conclusion:Applying Bufei Huoxue Huatan method in the treatment of chronic obstructive pulmonary disease complicated with pulmonary hypertension has a better therapeutic effectt,can significantly reduce the pulmonary artery systolic pressure.